Citadel Advisors’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$72.5M Sell
1,099,858
-63,079
-5% -$4.01M 0.05% 1052
2025
Q4
$73.9M Sell
1,162,937
-223,128
-16% -$13.9M 0.05% 1083
2025
Q3
$76.2M Buy
1,386,065
+87,456
+7% +$3.6M 0.06% 1039
2025
Q2
$42.9M Buy
1,298,609
+148,095
+13% +$5.15M 0.04% 1356
2025
Q1
$46.2M Sell
1,150,514
-221,131
-16% -$10.2M 0.05% 1216
2024
Q4
$64.5M Buy
1,371,645
+434,454
+46% +$22.6M 0.06% 1060
2024
Q3
$49.5M Buy
937,191
+78,218
+9% +$4.36M 0.05% 1220
2024
Q2
$46.5M Buy
858,973
+298,071
+53% +$18M 0.05% 1207
2024
Q1
$39.3M Buy
560,902
+288,309
+106% +$22.3M 0.04% 1408
2023
Q4
$22.8M Sell
272,593
-959,231
-78% -$34.7M 0.02% 1886
2023
Q3
$36.3M Buy
1,231,824
+331,835
+37% +$11.1M 0.04% 1345
2023
Q2
$29.4M Buy
+899,989
New +$33.3M 0.03% 1494
2023
Q1
Sell
-80,263
Closed -$3.27M 14856
2022
Q4
$3.68M Sell
80,263
-417,392
-84% -$18M ﹤0.01% 4398
2022
Q3
$24.1M Sell
497,655
-4,145,172
-89% -$200M 0.03% 1690
2022
Q2
$182M Buy
4,642,827
+4,370,177
+1,603% +$176M 0.25% 303
2022
Q1
$10M Buy
272,650
+240,717
+754% +$8.55M 0.01% 2956
2021
Q4
$1.46M Sell
31,933
-261,674
-89% -$10.1M ﹤0.01% 6952
2021
Q3
$10.5M Buy
293,607
+206,533
+237% +$6.08M 0.01% 2994
2021
Q2
$1.72M Sell
87,074
-234,642
-73% -$5.51M ﹤0.01% 6967
2021
Q1
$7.48M Buy
321,716
+221,545
+221% +$4.73M 0.01% 3453
2020
Q4
$2.08M Sell
100,171
-1,201,778
-92% -$22M ﹤0.01% 5280
2020
Q3
$28.2M Buy
1,301,949
+622,924
+92% +$14.6M 0.04% 1281
2020
Q2
$16M Sell
679,025
-485,691
-42% -$9.11M 0.02% 1703
2020
Q1
$13.7M Buy
1,164,716
+1,121,024
+2,566% +$14.3M 0.02% 1551
2019
Q4
$464K Sell
43,692
-10,806
-20% -$111K ﹤0.01% 6935
2019
Q3
$620K Buy
54,498
+2,959
+6% +$37.1K ﹤0.01% 6392
2019
Q2
$580K Sell
51,539
-95,090
-65% -$917K ﹤0.01% 6597
2019
Q1
$1.19M Sell
146,629
-73,824
-33% -$543K ﹤0.01% 5280
2018
Q4
$1.39M Buy
+220,453
New +$1.62M ﹤0.01% 4751
2018
Q3
Sell
-64,601
Closed -$518K 9297
2018
Q2
$536K Sell
64,601
-207,868
-76% -$1.73M ﹤0.01% 6257
2018
Q1
$1.96M Sell
272,469
-149,708
-35% -$1.28M ﹤0.01% 3766
2017
Q4
$3.44M Sell
422,177
-828,120
-66% -$9.4M ﹤0.01% 2928
2017
Q3
$18.1M Buy
1,250,297
+1,150,934
+1,158% +$15.7M 0.03% 1136
2017
Q2
$1.2M Buy
+99,363
New +$1.38M ﹤0.01% 3826
2017
Q1
Sell
-11,304
Closed -$132K 7534
2016
Q4
$137K Sell
11,304
-29,742
-72% -$316K ﹤0.01% 6548
2016
Q3
$377K Buy
+41,046
New +$429K ﹤0.01% 5299
2016
Q2
Sell
-14,551
Closed -$119K 6940
2016
Q1
$103K Buy
14,551
+9,576
+192% +$70K ﹤0.01% 6011
2015
Q4
$52K Sell
4,975
-16,388
-77% -$161K ﹤0.01% 7278
2015
Q3
$143K Buy
21,363
+2,016
+10% +$13.8K ﹤0.01% 6556
2015
Q2
$130K Sell
19,347
-162,015
-89% -$1.06M ﹤0.01% 6813
2015
Q1
$1.23M Buy
181,362
+62,898
+53% +$470K ﹤0.01% 3665
2014
Q4
$949K Buy
118,464
+32,366
+38% +$139K ﹤0.01% 3832
2014
Q3
$303K Buy
86,098
+62,843
+270% +$264K ﹤0.01% 5248
2014
Q2
$111K Sell
23,255
-121,119
-84% -$739K ﹤0.01% 6151
2014
Q1
$1.37M Buy
+144,374
New +$1.31M ﹤0.01% 3030

Other funds holding CYTK